Guinea-Bissau - WESTERN AND CENTRAL AFRICA - P176721 - GUINEA-BISSAU COVID-19 VACCINE PROJECT - Audited Financial Statement (English)

Document also available in : English

DETAILS

Author

Jorge Humberto Da Silva;
Document Date
2023/11/15
Document Type
Auditing Document
Report Number
SCA0094796
Country
Guinea-Bissau,
Region
Western and Central Africa,
Disclosure Date
2023/11/27
Disclosure Status
Disclosed
Doc Name
Guinea-Bissau - WESTERN AND CENTRAL AFRICA - P176721 - GUINEA-BISSAU COVID-19 VACCINE PROJECT - Audited Financial Statement

Language

English

Rel. Proj ID

GW-GUINEA-BISSAU COVID-19 VACCINE PROJECT -- P176721

Major Sector

FY17 - Health

Theme

FY17 - Climate change,FY17 - Health Finance,FY17 - Other Excluded Groups,FY17 - Disease Control,FY17 - Mitigation,FY17 - Pandemic Response,FY17 - Health Service Delivery,FY17 - Social Inclusion,FY17 - Gender,FY17 - Health Systems and Policies,FY17 - Health System Strengthening,FY17 - Adaptation

Sector

FY17 - Health,FY17 - Public Administration - Health

Unit Owning

Health Nutrition&Population AFR2 (HAWH2)

Lending Instrument

Investment Project Financing

Version Type

Final

Product Line

IBRD/IDA

Citation

Jorge Humberto Da Silva.

Guinea-Bissau - WESTERN AND CENTRAL AFRICA - P176721 - GUINEA-BISSAU COVID-19 VACCINE PROJECT - Audited Financial Statement (English). Washington, D.C. : World Bank Group. http://documents.worldbank.org/curated/en/099112723000510805

Guinea-Bissau - WESTERN AND CENTRAL AFRICA - P176721 - GUINEA-BISSAU COVID-19 VACCINE PROJECT - Audited Financial Statement (English)

DETAILS

Citation

RELATED LINKS

SUBSCRIBE TO EMAIL ALERTS